a0B%2
5)::92*_!i>A>!K$((0_!i>@>_!=<0c2*&%2!Q>!"2**0%_!=>Q>_!S#2C*2Y$_!Q>!=30%*0(#4_!5>Q>_!8%2$*_!A>O>_!S$B<$*)_!/>R>_!A23<0_! ;>_!A0Y4_!5>!=>_!O)BD#0%(4!!O>O?_!'Y2*_!I>8>_!L2Y2!_!@>[+,-]^? ! 0%>#@B&'#%*)?,"#(&"!&6>??%((!>B&`#)%!&'(A?-"*A+@$)?& '(A?-",-%#@:A&!"#&'%#()(,%+,&;%:#%(()"+ d !/647#)(#0%!/647#)6)9!+,-]qbP?Pg]h NM` ! >-001(3! Psychodynamic psychotherapy has been used to treat depression for more than a century. However, not all patients respond equally well, and there are few reliable predictors of treatment outcome. =&.4$'2! We used resting 18 F-fluorodeoxyglucose positron emission tomography ( 18 FDG-PET) scans immediately before and after a structured, open trial of brief psychodynamic psychotherapy (n = 16) in conjunction with therapy process ratings and clinical outcome measures to identify neural correlates of treatment response. ;&2-5.2! Pretreatment glucose metabolism within the right posterior insula correlated with depression severity. Reductions in depression scores correlated with a pre- to posttreatment reduction in right insular metabolism, which in turn correlated with higher objective measures of patient insight obtained from videotaped therapy sessions. Pretreatment metabolism in the right precuneus was significantly higher in patients who completed treatment and correlated with psychological mindedness. G$#/5-2*$#2! Resting brain metabolism predicted both clinical course and relevant psychotherapeutic process during short-term psychodynamic psychotherapy for depression. G$#.1/.\!
Joshua L. Roffman, MD, MMSc Massachusetts General Hospital Room 2606, 149 13th Street Charlestown, MA 02129 (USA) E-Mail jroffman @ partners.org
NNO
.01230/1.40/5&&'67894/0/571.8/5&&/6648./1.40&
Made with FlippingBook HTML5